The DOI matches its Crossref record.
Randomized trial of three rapamycin-eluting stents with different coating strategies for the reduction of coronary restenosis
Open accessAbstract
AIMS: The objective of this study was to assess the non-inferiority, in terms of anti-restenotic efficacy, of both biodegradable-polymer (BP) and polymer-free (PF) stents compared with permanent-polymer rapamycin-eluting (PP; Cypher) stent. METHODS AND RESULTS: Patients with de novo coronary lesions in native vessels were randomly assigned to receive a BP stent, a PF stent or a PP stent. The primary endpoint was in-stent late lumen loss at follow-up angiogram. A total of 605 patients were enrolled: 202 patients received BP stents, 202 were treated with PP stents, and 201 received PF stents. Repeat angiography was available for 492 patients (81.3%). Mean late lumen loss at 6-8-month angiographic follow-up was 0.17 +/- 0.45 mm in the BP stent group, 0.23 +/- 0.46 mm in the PP cohort, and 0.47 +/- 0.56 mm in the PF stent group. The BP stent met pre-specified criteria for non-inferiority (P < 0.001), whereas the PF stent did not (P = 0.94). There were no differences in safety outcomes. CONCLUSION: Both BP and PF stents have a 1-year safety profile similar to that of the PP stent. Whereas the PF stent provided an inferior efficacy, the BP stent is at least as effective as the PP stent in terms of anti-restenotic efficacy.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Stefanini, G. G., Byrne, R. A., Serruys, P. W., de Waha, A., Meier, B., Massberg, S., Juni, P., Schomig, A., Windecker, S., & Kastrati, A. (2012) · European Heart Journal · doi:10.1093/eurheartj/ehs086 · Cited by 384
Self-citationStefanini, G. G., Kalesan, B., Serruys, P. W., Heg, D., Buszman, P., Linke, A., Ischinger, T., Klauss, V., Eberli, F., Wijns, W., et al. (2011) · The Lancet · doi:10.1016/s0140-6736(11)61672-3 · Cited by 354
Garg, S., & Serruys, P. W. (2010) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2010.06.008 · Cited by 306
Smits, P. C., Hofma, S., Togni, M., Vázquez, N., Valdés, M., Voudris, V., Slagboom, T., Goy, J.-J., Vuillomenet, A., Serra, A., et al. (2013) · The Lancet · doi:10.1016/s0140-6736(12)61852-2 · Cited by 293
New concepts in the design of drug-eluting coronary stents
Garg, S., Bourantas, C., & Serruys, P. W. (2013) · Nature Reviews Cardiology · doi:10.1038/nrcardio.2013.13 · Cited by 125
Metadata
- Authors
- Mehilli, J., Byrne, R. A., Wieczorek, A., Iijima, R., Schulz, S., Bruskina, O., Pache, J., Wessely, R., Schomig, A., Kastrati, A., & for the Intracoronary Stenting and Angiographic Restenosis Investigators - Test Efficacy of Rapamycin-eluting Stents with Different Polymer Coating Strategies (ISAR-TEST-3)
- Venue
- European Heart Journal
- Publisher
- Oxford University Press (OUP)
- Published
- 2008-07-10
- Volume
- 29
- Issue
- 16
- Pages
- 1975-1982
- ISSN
- 0195-668X (ISSN-L)
- 1522-9645
- OpenAlex
- W2156104055
- Cited by
- 196
- References
- 0
- FWCI
- 16.49
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Randomized trial of three rapamycin-eluting stents with different coating strategies for the reduction of coronary restenosis. https://app.cochat.ai/papers/10.1093/eurheartj/ehn253
- The paper
- Mehilli, J., Byrne, R. A., Wieczorek, A., Iijima, R., Schulz, S., Bruskina, O., Pache, J., Wessely, R., Schomig, A., Kastrati, A., & for the Intracoronary Stenting and Angiographic Restenosis Investigators - Test Efficacy of Rapamycin-eluting Stents with Different Polymer Coating Strategies (ISAR-TEST-3). (2008). Randomized trial of three rapamycin-eluting stents with different coating strategies for the reduction of coronary restenosis. European Heart Journal. https://doi.org/10.1093/eurheartj/ehn253
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.